AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie u.S. Retail Sales: Pharmacies and Drug Stores — Not Seasonally Adjusted ($M) ($M)
FRED (MRTSSM44611USN)
Latest, FY2025
404,300
Period ended Dec 31, 2025
Change on a year earlier
+8.6%
372,264 in FY2024
History
10 years
Since FY2016
Sources
1
FRED (MRTSSM44611USN)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Retail Sales: Pharmacies and Drug Stores — Not Seasonally Adjusted ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 404,300 | +8.6% | FRED (MRTSSM44611USN) ↗ |
| FY2024 | Dec 31, 2024 | 372,264 | +8.4% | FRED (MRTSSM44611USN) ↗ |
| FY2023 | Dec 31, 2023 | 343,553 | +6.3% | FRED (MRTSSM44611USN) ↗ |
| FY2022 | Dec 31, 2022 | 323,048 | +3.3% | FRED (MRTSSM44611USN) ↗ |
| FY2021 | Dec 31, 2021 | 312,714 | +6.0% | FRED (MRTSSM44611USN) ↗ |
| FY2020 | Dec 31, 2020 | 295,027 | +4.1% | FRED (MRTSSM44611USN) ↗ |
| FY2019 | Dec 31, 2019 | 283,352 | +2.3% | FRED (MRTSSM44611USN) ↗ |
| FY2018 | Dec 31, 2018 | 276,924 | +3.1% | FRED (MRTSSM44611USN) ↗ |
| FY2017 | Dec 31, 2017 | 268,659 | +2.3% | FRED (MRTSSM44611USN) ↗ |
| FY2016 | Dec 31, 2016 | 262,555 | – | FRED (MRTSSM44611USN) ↗ |
Cite this data
StockData. (2026). AbbVie U.S. Retail Sales: Pharmacies and Drug Stores — Not Seasonally Adjusted ($M) ($M), annual FY2016–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fred_rx_retail_nsa
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.